(Q44961457)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

0 references

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Charles H Chesnut

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Arne Skag

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Claus Christiansen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Robert Recker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Jacob A Stakkestad

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Arne Hoiseth

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Dieter Felsenberg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Hermann Huss

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Ralph C Schimmer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Pierre D Delmas

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE)

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

29 March 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

Journal of Bone and Mineral Research

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

1241-1249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

The economic and human costs of osteoporotic fracture

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Bisphosphonates: pharmacology, mechanisms of action and clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Esophagitis associated with the use of alendronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Weekly administration of alendronate: rationale and plan for clinical assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Ibandronate: a comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: a review of three phase II studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Noninvasive assessment of bone mineral and structure: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Two years' effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Efficacy and safety of ibandronate given by intravenous injection once every 3 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040325

21 January 2018

Identifiers

DOI

10.1359/JBMR.040325

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15231010%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference